News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Katz Barrett
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 4,147 shares
@ $37.01, valued at
$153.5k
Sold 24,853 shares
@ $37.21, valued at
$924.8k
Exercised 4,147 options to buy
@ $23.03, valued at
$95.5k
Exercised 24,853 options to buy
@ $23.03, valued at
$572.4k
|
|
| 01/11/2023 |
4
| Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 12,623 shares
@ $33.04, valued at
$417.1k
Sold 47,377 shares
@ $35.3, valued at
$1.7M
Exercised 12,623 options to buy
@ $23.03, valued at
$290.7k
Exercised 47,377 options to buy
@ $23.03, valued at
$1.1M
|
|
| 01/21/2021 |
3
| Katz Barrett (Chief Medical Officer) has filed a Form 3 on Viridian Therapeutics, Inc.\DE |
| 01/21/2021 |
4
| Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 356,000 options to buy
@ $23.03, valued at
$8.2M
|
|
|
|